170 related articles for article (PubMed ID: 37587270)
1. Characteristics of Asian Participation in Multi-regional Clinical Trials Reviewed for Drug Approval in Japan: Opportunities for Collaboration Between South-East Asia, East Asia, and Japan.
Aoi Y; Kato Y; Asano K; Otsubo Y; Uyama Y
Ther Innov Regul Sci; 2023 Nov; 57(6):1298-1303. PubMed ID: 37587270
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Drug Lags in Development Initiation, New Drug Application and Approval Between Japan and the USA and the Impact of Local Versus Multi-regional Clinical Trials.
Ushijima S; Matsumaru N; Tsukamoto K
Pharmaceut Med; 2021 Jul; 35(4):253-260. PubMed ID: 34291425
[TBL] [Abstract][Full Text] [Related]
3. Efficacy Comparison for a Schizophrenia and a Dysuria Drug Among East Asian Populations: A Retrospective Analysis Using Multi-regional Clinical Trial Data.
Sai K; Nakatani E; Iwama Y; Hiraoka S; Tohkin M; Uyama Y; Saito Y
Ther Innov Regul Sci; 2021 May; 55(3):523-538. PubMed ID: 33393013
[TBL] [Abstract][Full Text] [Related]
4. The necessary conduct: Exploratory multiregional clinical trials in East Asia.
Jeon I; Kim YK; Song I; Yoon DY; Huh KY; Jin X; Yu KS; Lee S; Kumagai Y; Jang IJ
Clin Transl Sci; 2021 Nov; 14(6):2399-2407. PubMed ID: 34397152
[TBL] [Abstract][Full Text] [Related]
5. Potential Future Drug Development Lag in Japan Based on an Analysis of Multiregional Clinical Trials in the US, Europe, and East Asia.
Noguchi A; Hanaoka H; Uyama Y
Ther Innov Regul Sci; 2022 May; 56(3):523-529. PubMed ID: 35181842
[TBL] [Abstract][Full Text] [Related]
6. Comparison of global versus Asian clinical trial strategies supportive of registration of drugs in Japan.
Shirotani M; Kurokawa T; Chiba K
J Clin Pharmacol; 2014 Jul; 54(7):753-64. PubMed ID: 24496890
[TBL] [Abstract][Full Text] [Related]
7. Asia-inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial.
Zhou X; Friedlander S; Kupperman E; Sedarati F; Kuroda S; Hua Z; Yuan Y; Yamamoto Y; Faller DV; Haikawa K; Nakai K; Bowen S; Dai Y; Venkatakrishnan K
Clin Transl Sci; 2021 May; 14(3):1069-1081. PubMed ID: 33503305
[TBL] [Abstract][Full Text] [Related]
8. Points to Consider for Implementation of the ICH E17 Guideline: Learning from Past Multiregional Clinical Trials in Japan.
Asano K; Aoi Y; Kamada S; Uyama Y; Tohkin M
Clin Pharmacol Ther; 2021 Jun; 109(6):1555-1563. PubMed ID: 33245786
[TBL] [Abstract][Full Text] [Related]
9. Asia-Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo.
Venkatakrishnan K; Gupta N; Smith PF; Lin T; Lineberry N; Ishida T; Wang L; Rogge M
Clin Pharmacol Ther; 2023 Feb; 113(2):298-309. PubMed ID: 35342942
[TBL] [Abstract][Full Text] [Related]
10. Application of estimand framework to the design and analysis of multi-regional clinical trials.
Niu C; Liang L; Fu R; Zhong W; Wang WWB
J Biopharm Stat; 2024 Jun; ():1-17. PubMed ID: 38840476
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Current Status and Open Issues Concerning Global Clinical Trials (GCTs) in Japan and East Asia.
Miyazaki K; Sato Y; Hanaoka H; Uyama Y
Clin Transl Sci; 2017 Nov; 10(6):503-508. PubMed ID: 28675655
[TBL] [Abstract][Full Text] [Related]
13. Influence Diagnostics of a Region of Interest in Multi-regional Clinical Trials.
Kuribayashi K; Cao C
Ther Innov Regul Sci; 2023 Mar; 57(2):220-226. PubMed ID: 36109434
[TBL] [Abstract][Full Text] [Related]
14. Population/regional differences in efficacy of 3 drug categories (antidiabetic, respiratory and psychotropic agents) among East Asians: A retrospective study based on multiregional clinical trials.
Sai K; Yoshida A; Hanatani T; Imatoh T; Takeuchi M; Narukawa M; Watanabe H; Uyama Y; Saito Y
Br J Clin Pharmacol; 2019 Jun; 85(6):1270-1282. PubMed ID: 30735569
[TBL] [Abstract][Full Text] [Related]
15. International oncology drug approvals for multiregional or single-country clinical trials: A systematic review.
Zhang M; Onakpoya I; Rupalla K
Front Med (Lausanne); 2022; 9():1084980. PubMed ID: 36590932
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated with Inclusion of Japan in Phase I Multiregional Clinical Trials in Oncology.
Maki A; Narukawa M
Ther Innov Regul Sci; 2024 Jul; 58(4):766-772. PubMed ID: 38652349
[TBL] [Abstract][Full Text] [Related]
17. Establishing consistency across all regions in a multi-regional clinical trial.
Tsou HH; James Hung HM; Chen YM; Huang WS; Chang WJ; Hsiao CF
Pharm Stat; 2012; 11(4):295-9. PubMed ID: 22504851
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the Safety Profiles of Japanese Clinical Trials.
Kanmuri K; Narukawa M
Ther Innov Regul Sci; 2014 May; 48(3):308-315. PubMed ID: 30235536
[TBL] [Abstract][Full Text] [Related]
19. East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective.
Enomoto T; Okamoto A; Kim JH; Lai CH; Wu X; Kim YM
J Gynecol Oncol; 2023 Sep; 34(5):e86. PubMed ID: 37593814
[TBL] [Abstract][Full Text] [Related]
20. Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs.
Hata T; Nakamura K; Yonemori K; Noguchi E; Watanabe M; Sohn J; Lu YS; Yap YS; Tamura K; Fujiwara Y
Clin Transl Sci; 2021 May; 14(3):1015-1025. PubMed ID: 33382914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
